David C. Seldin - Publications

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Biochemistry, Oncology

168 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tahir UA, Doros G, Kim JS, Connors LH, Seldin DC, Sam F. Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure. Scientific Reports. 9: 8552. PMID 31189919 DOI: 10.1038/s41598-019-44912-x  0.72
2016 Lian H, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, Tang KC, Roderick JE, Kelliher MA, Seldin DC, Fu H, Feng H. CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica. PMID 27758824 DOI: 10.3324/haematol.2016.154013  1
2016 Prokaeva T, Spencer B, Sun F, O'Hara RM, Seldin DC, Connors LH, Sanchorawala V. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-7. PMID 27677679 DOI: 10.1080/13506129.2016.1219715  1
2016 Shu J, Lo S, Phillips M, Sun F, Seldin DC, Berenbaum I, Berk JL, Sanchorawala V. Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients (.) Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-6. PMID 27460276 DOI: 10.1080/13506129.2016.1208081  1
2016 Sanchorawala V, Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC. Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase I and II trial. Blood. PMID 27381904 DOI: 10.1182/blood-2016-04-710822  1
2016 Lee SY, Meehan RS, Seldin DC, Sloan JM, Quillen K, Shelton A, Brauneis D, Sanchorawala V. Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis. Bone Marrow Transplantation. PMID 27183092 DOI: 10.1038/bmt.2016.132  1
2016 Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ, Sherr DH. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. Bmc Biology. 14: 20. PMID 26984638 DOI: 10.1186/s12915-016-0240-y  1
2015 Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC. Heart Failure Due to Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study. Circulation. PMID 26660282 DOI: 10.1161/CIRCULATIONAHA.115.018852  0.72
2015 Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20 year experience. Blood. PMID 26443620 DOI: 10.1182/blood-2015-08-662726  1
2015 Sarosiek S, Seldin DC, Connors LH, Spencer B, Murakami A, O'Hara C, Sanchorawala V. Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 22: 156-62. PMID 26104853 DOI: 10.3109/13506129.2015.1036983  1
2015 Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. Embo Molecular Medicine. 7: 688. PMID 25940533 DOI: 10.15252/emmm.201505318  1
2015 Sanchorawala V, Brauneis D, Shelton AC, Lo S, Sun F, Sloan JM, Quillen K, Seldin DC. Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1445-51. PMID 25858810 DOI: 10.1016/j.bbmt.2015.04.001  1
2015 Renteria AS, Sanchorawala V, Niehaus ED, Sun F, Semigran MJ, Seldin DC. Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis. Bone Marrow Transplantation. 50: 868-9. PMID 25751645 DOI: 10.1038/bmt.2015.9  1
2015 Greene MJ, Klimtchuk ES, Seldin DC, Berk JL, Connors LH. Cooperative stabilization of transthyretin by clusterin and diflunisal. Biochemistry. 54: 268-78. PMID 25478940 DOI: 10.1021/bi5011249  1
2015 Sikora JL, Logue MW, Chan GG, Spencer BH, Prokaeva TB, Baldwin CT, Seldin DC, Connors LH. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt). Human Genetics. 134: 111-21. PMID 25367359 DOI: 10.1007/s00439-014-1499-0  1
2014 Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. Embo Molecular Medicine. 6: 1493-507. PMID 25319546 DOI: 10.15252/emmm.201404190  1
2014 Fu J, Seldin DC, Berk JL, Sun F, O'Hara C, Cui H, Sanchorawala V. Lymphadenopathy as a manifestation of amyloidosis: a case series. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 21: 256-60. PMID 25208081 DOI: 10.3109/13506129.2014.958610  1
2014 Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V. Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis. Bone Marrow Transplantation. 49: 1345-6. PMID 24955784 DOI: 10.1038/bmt.2014.132  1
2014 Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 21: 149-53. PMID 24779777 DOI: 10.3109/13506129.2014.900486  1
2014 Lichtman EI, Seldin DC, Shelton A, Sanchorawala V. Single agent lenalidomide three times a week induces hematologic responses in AL amyloidosis patients on dialysis. American Journal of Hematology. 89: 706-8. PMID 24668858 DOI: 10.1002/ajh.23722  1
2014 Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA. Immunoglobulin light chain amyloidosis. Expert Review of Hematology. 7: 143-56. PMID 24350907 DOI: 10.1586/17474086.2014.858594  1
2014 Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplantation. 49: 434-9. PMID 24317129 DOI: 10.1038/bmt.2013.192  1
2014 Gray Gilstrap L, Niehaus E, Malhotra R, Ton VK, Watts J, Seldin DC, Madsen JC, Semigran MJ. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 33: 149-56. PMID 24200511 DOI: 10.1016/j.healun.2013.09.004  1
2014 Seldin DC. Light-Chain Amyloidosis Cancer Consult: Expertise For Clinical Practice. 366-370. DOI: 10.1002/9781118589199.ch57  1
2013 Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, ... ... Seldin DC, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. Jama. 310: 2658-67. PMID 24368466 DOI: 10.1001/jama.2013.283815  1
2013 Leung A, Nah SK, Reid W, Ebata A, Koch CM, Monti S, Genereux JC, Wiseman RL, Wolozin B, Connors LH, Berk JL, Seldin DC, Mostoslavsky G, Kotton DN, Murphy GJ. Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports. 1: 451-63. PMID 24286032 DOI: 10.1016/j.stemcr.2013.10.003  1
2013 Guan J, Mishra S, Shi J, Plovie E, Qiu Y, Cao X, Gianni D, Jiang B, Del Monte F, Connors LH, Seldin DC, Lavatelli F, Rognoni P, Palladini G, Merlini G, et al. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Research in Cardiology. 108: 378. PMID 23982491 DOI: 10.1007/s00395-013-0378-5  1
2013 Sanchorawala V, Hoering A, Seldin DC, Finn KT, Fennessey SA, Sexton R, Mattar B, Safah HF, Holmberg LA, Dean RM, Orlowski RZ, Barlogie B. Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115. Bone Marrow Transplantation. 48: 1537-42. PMID 23852321 DOI: 10.1038/bmt.2013.98  1
2013 Girnius S, Seldin DC, Cibeira MT, Sanchorawala V. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2749-50. PMID 23775968 DOI: 10.1200/JCO.2013.48.7736  1
2013 Sanchorawala V, Shelton AC, Zeldis JB, Seldin DC. Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide. American Journal of Hematology. 88: 719. PMID 23650113 DOI: 10.1002/ajh.23470  1
2013 Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, MacRae CA, Liao R. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. American Journal of Physiology. Heart and Circulatory Physiology. 305: H95-103. PMID 23624626 DOI: 10.1152/ajpheart.00186.2013  1
2013 Tanaka K, Essick EE, Doros G, Tanriverdi K, Connors LH, Seldin DC, Sam F. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis. Journal of the American Heart Association. 2: e005868. PMID 23537813 DOI: 10.1161/JAHA.112.005868  1
2013 Sarosiek S, Seldin DC, Berk JL, Sanchorawala V. A solitary mediastinal mass due to localized AL amyloidosis: case report and review of the literature. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 20: 127-30. PMID 23461593 DOI: 10.3109/13506129.2013.775644  1
2013 Taimur S, Nader C, Lloyd-Travaglini C, Seldin DC, Sanchorawala V. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis Transplant Infectious Disease. 15: 187-194. PMID 23279695 DOI: 10.1111/tid.12037  1
2013 Sanchorawala V, Patel JM, Sloan JM, Shelton AC, Zeldis JB, Seldin DC. Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial. Haematologica. 98: 789-92. PMID 23144200 DOI: 10.3324/haematol.2012.075192  1
2013 Cowan AJ, Skinner M, Seldin DC, Berk JL, Lichtenstein DR, O'Hara CJ, Doros G, Sanchorawala V. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 98: 141-6. PMID 22733017 DOI: 10.3324/haematol.2012.068155  1
2013 Seldin DC, Landesman-Bollag E. The Oncogenic Potential of CK2 Protein Kinase Ck2. 292-304. DOI: 10.1002/9781118482490.ch10  1
2012 Imbrie GA, Wu H, Seldin DC, Dominguez I. Asymmetric Localization of CK2α During Xenopus Oogenesis. Human Genetics & Embryology : Current Research. 11328. PMID 25346867 DOI: 10.4172/2161-0436.S4-001  0.6
2012 Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 120: 4445-6. PMID 23175664 DOI: 10.1182/blood-2012-09-457341  1
2012 Shin JT, Ward JE, Collins PA, Dai M, Semigran HL, Semigran MJ, Seldin DC. Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 19: 191-6. PMID 23126591 DOI: 10.3109/13506129.2012.733741  1
2012 Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Research. 72: 6268-78. PMID 23054396 DOI: 10.1158/0008-5472.CAN-12-2270  1
2012 Girnius S, Skinner M, Spencer B, Prokaeva T, Bartholomew C, O'Hara C, Seldin DC, Connors LH. A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 19: 182-5. PMID 22978355 DOI: 10.3109/13506129.2012.723074  1
2012 Lee JC, Wu H, Prokaeva TB, O'Hara C, Seldin DC. Expression of D-type cyclins in AL amyloidosis plasma cells. Journal of Clinical Pathology. 65: 1052-5. PMID 22859391 DOI: 10.1136/jclinpath-2012-200819  1
2012 Cowan AJ, Seldin DC, Skinner M, Quillen K, Doros G, Tan J, O'Hara C, Finn KT, Sanchorawala V. Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1935-8. PMID 22842332 DOI: 10.1016/j.bbmt.2012.07.016  1
2012 Shi X, Seldin DC, Garry DJ. Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. The Biochemical Journal. 446: 349-57. PMID 22716292 DOI: 10.1042/BJ20120563  1
2012 Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 19: 156-60. PMID 22680044 DOI: 10.3109/13506129.2012.694825  1
2012 Sanchorawala V, Seldin DC. AL amyloidosis: who, what, when, why, and where. Oncology (Williston Park, N.Y.). 26: 164, 166, 169. PMID 22489350  1
2012 Seldin DC, Sanchorawala V. Amyloidomics comes of age. Blood. 119: 1795-6. PMID 22361969 DOI: 10.1182/blood-2011-10-381178  1
2012 Flies A, Ahmadi T, Parks AJ, Prokaeva T, Weng L, Rolfe SS, Seldin DC, Sherr DH. Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis. Immunology and Cell Biology. 90: 528-39. PMID 21894172 DOI: 10.1038/icb.2011.73  1
2011 Ward JE, Ren R, Toraldo G, Soohoo P, Guan J, O'Hara C, Jasuja R, Trinkaus-Randall V, Liao R, Connors LH, Seldin DC. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood. 118: 6610-7. PMID 21998211 DOI: 10.1182/blood-2011-04-351643  1
2011 Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica. 96: 1890-2. PMID 21859734 DOI: 10.3324/haematol.2011.049858  1
2011 Moscetti A, Saltarelli F, Bianchi MP, Monarca B, De Biase L, Porrini R, Antolino G, La Verde G. Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 152-4. PMID 21838469 DOI: 10.3109/13506129.2011.574354057  1
2011 Meier-Ewert HK, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Ruberg FL. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 125-126. PMID 21838460  1
2011 Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, et al. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 127-9. PMID 21838459 DOI: 10.3109/13506129.2011.574354047  1
2011 Ward JE, SooHoo P, Toraldo G, Jasuja R, Connors LH, O'Hara C, Seldin DC. Metabolic phenotype in an AL amyloidosis transgenic mouse model. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 40-1. PMID 21838426 DOI: 10.3109/13506129.2011.574354014  0.72
2011 Weng L, Spencer BH, SoohHoo PT, Connors LH, O'Hara CJ, Seldin DC. Dysregulation of miRNAs in AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 128-35. PMID 21834602 DOI: 10.3109/13506129.2011.588977  1
2011 Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 118: 4346-52. PMID 21828140 DOI: 10.1182/blood-2011-01-330738  1
2011 Landesman-Bollag E, Belkina A, Hovey B, Connors E, Cox C, Seldin DC. Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Molecular and Cellular Biochemistry. 356: 227-31. PMID 21769451 DOI: 10.1007/s11010-011-0967-2  1
2011 Dominguez I, Degano IR, Chea K, Cha J, Toselli P, Seldin DC. CK2α is essential for embryonic morphogenesis. Molecular and Cellular Biochemistry. 356: 209-16. PMID 21761203 DOI: 10.1007/s11010-011-0961-8  1
2011 Seldin DC, Berk JL, Sam F, Sanchorawala V. Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment. Heart Failure Clinics. 7: 385-93. PMID 21749890 DOI: 10.1016/j.hfc.2011.03.009  1
2011 Hovey BM, Ward JE, Soo Hoo P, O'Hara CJ, Connors LH, Seldin DC. Preclinical development of siRNA therapeutics for AL amyloidosis. Gene Therapy. 18: 1150-6. PMID 21562591 DOI: 10.1038/gt.2011.69  1
2011 Tsai SB, Seldin DC, Wu H, O'Hara C, Ruberg FL, Sanchorawala V. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 160-4. PMID 21504342 DOI: 10.3109/13506129.2011.571319  1
2011 Charlot M, Seldin DC, O'hara C, Skinner M, Sanchorawala V. Localized amyloidosis of the breast: a case series. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 72-5. PMID 21501022 DOI: 10.3109/13506129.2011.570817  1
2011 Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1924-33. PMID 21483018 DOI: 10.1200/JCO.2010.32.2271  1
2011 Cowan AJ, Skinner M, Berk JL, Sloan JM, O'hara C, Seldin DC, Sanchorawala V. Macroglossia - not always AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 18: 83-6. PMID 21401321 DOI: 10.3109/13506129.2011.560217  1
2011 Greene MJ, Sam F, Soo Hoo PT, Patel RS, Seldin DC, Connors LH. Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. The American Journal of Pathology. 178: 61-8. PMID 21224044 DOI: 10.1016/j.ajpath.2010.11.015  1
2011 Quillen K, Seldin DC, Finn KT, Sanchorawala V. A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis Bone Marrow Transplantation. 46: 976-980. PMID 20956955 DOI: 10.1038/bmt.2010.239  1
2011 Specter R, Sanchorawala V, Seldin DC, Shelton A, Fennessey S, Finn KT, Zeldis JB, Dember LM. Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 881-6. PMID 20693160 DOI: 10.1093/ndt/gfq482  1
2011 Girnius S, Seldin DC, Quillen K, Dember LM, Segal A, Sanchorawala V. Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation Bone Marrow Transplantation. 46: 161-162. PMID 20383204 DOI: 10.1038/bmt.2010.82  1
2010 Sanchorawala V, Seldin DC, Berk JL, Sloan JM, Doros G, Skinner M. Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clinical Lymphoma, Myeloma & Leukemia. 10: 469-72. PMID 21156464 DOI: 10.3816/CLML.2010.n.081  1
2010 Tapan U, Seldin DC, Finn KT, Fennessey S, Shelton A, Zeldis JB, Sanchorawala V. Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis. Blood. 116: 5071-2. PMID 21127185 DOI: 10.1182/blood-2010-09-305136  1
2010 Klimtchuk ES, Gursky O, Patel RS, Laporte KL, Connors LH, Skinner M, Seldin DC. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry. 49: 9848-57. PMID 20936823 DOI: 10.1021/bi101351c  1
2010 Ren R, Hong Z, Gong H, Laporte K, Skinner M, Seldin DC, Costello CE, Connors LH, Trinkaus-Randall V. Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils. The Journal of Biological Chemistry. 285: 37672-82. PMID 20870723 DOI: 10.1074/jbc.M110.149575  1
2010 Sanchorawala V, Finn KT, Fennessey S, Shelton A, Doros G, Zeldis JB, Seldin DC. Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis. Blood. 116: 1990-1. PMID 20847211 DOI: 10.1182/blood-2010-07-295485  1
2010 Dey BR, Chung SS, Spitzer TR, Zheng H, MacGillivray TE, Seldin DC, McAfee S, Ballen K, Attar E, Wang T, Shin J, Newton-Cheh C, Moore S, Sanchorawala V, Skinner M, et al. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure Transplantation. 90: 905-911. PMID 20733534 DOI: 10.1097/TP.0b013e3181f10edb  1
2010 Shahid M, Shen L, Seldin DC, Lu B, Ustyugova IV, Chen X, Zapol WM, Wu MX. Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cells. Hypertension. 56: 705-12. PMID 20713914 DOI: 10.1161/HYPERTENSIONAHA.110.154880  1
2010 Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proceedings of the National Academy of Sciences of the United States of America. 107: 4188-93. PMID 20150510 DOI: 10.1073/pnas.0912263107  1
2010 Currier N, Chea K, Hlavacova M, Sussman DJ, Seldin DC, Dominguez I. Dynamic expression of a LEF-EGFP Wnt reporter in mouse development and cancer. Genesis (New York, N.Y. : 2000). 48: 183-94. PMID 20146356 DOI: 10.1002/dvg.20604  1
2010 Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Annals of Hematology. 89: 579-84. PMID 20012043 DOI: 10.1007/s00277-009-0874-8  1
2010 Rosenzweig M, Seldin DC, Remick DG, Skinner M, Quillen K, Oran B, Finn KT, Sanchorawala V. Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction. Bone Marrow Transplantation. 45: 21-4. PMID 19421171 DOI: 10.1038/bmt.2009.94  1
2009 Tam M, Seldin DC, Forbes BM, Connors LH, Skinner M, Oran B, Quillen K, Sanchorawala V. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 16: 103-7. PMID 20536404 DOI: 10.1080/13506120902879574  1
2009 Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. American Heart Journal. 158: 607-14. PMID 19781421 DOI: 10.1016/j.ahj.2009.08.006  1
2009 Wu H, Symes K, Seldin DC, Dominguez I. Threonine 393 of beta-catenin regulates interaction with Axin. Journal of Cellular Biochemistry. 108: 52-63. PMID 19565571 DOI: 10.1002/jcb.22260  1
2009 Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica. 94: 1029-32. PMID 19454500 DOI: 10.3324/haematol.2008.001925  1
2009 Dominguez I, Sonenshein GE, Seldin DC. CK2 and its role in Wnt and NF-κB signaling: Linking development and cancer Cellular and Molecular Life Sciences. 66: 1850-1857. PMID 19387549 DOI: 10.1007/s00018-009-9153-z  1
2009 Near RI, Smith RS, Toselli PA, Freddo TF, Bloom AB, Vanden Borre P, Seldin DC, Lerner A. Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens. Molecular Vision. 15: 685-99. PMID 19365570  1
2009 Bodi K, Prokaeva T, Spencer B, Eberhard M, Connors LH, Seldin DC. AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 16: 1-8. PMID 19291508 DOI: 10.1080/13506120802676781  1
2008 Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Seldin DS, Sam F. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circulation. Heart Failure. 1: 249-57. PMID 19808299 DOI: 10.1161/CIRCHEARTFAILURE.108.788687  1
2008 Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nature Cell Biology. 10: 1208-16. PMID 18806787 DOI: 10.1038/ncb1781  1
2008 Seldin DC, Lou DY, Toselli P, Landesman-Bollag E, Dominguez I. Gene targeting of CK2 catalytic subunits. Molecular and Cellular Biochemistry. 316: 141-7. PMID 18594950 DOI: 10.1007/s11010-008-9811-8  1
2008 Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Théberge R, Connors LH, Bellotti V, Seldin DC, Merlini G, Skinner M, Costello CE. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Molecular & Cellular Proteomics : McP. 7: 1570-83. PMID 18474516 DOI: 10.1074/mcp.M700545-MCP200  1
2008 Lou DY, Dominguez I, Toselli P, Landesman-Bollag E, O'Brien C, Seldin DC. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Molecular and Cellular Biology. 28: 131-9. PMID 17954558 DOI: 10.1128/MCB.01119-07  1
2008 Seldin DC. The Future of Molecular Diagnostics and Targeted Therapeutics in the Amyloidoses Amyloid Proteins: the Beta Sheet Conformation and Disease. 1: 343-354. DOI: 10.1002/9783527619344.ch15  1
2007 Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Research. 67: 11742-50. PMID 18089804 DOI: 10.1158/0008-5472.CAN-07-2730  1
2007 Connors LH, Jiang Y, Budnik M, Théberge R, Prokaeva T, Bodi KL, Seldin DC, Costello CE, Skinner M. Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry. 46: 14259-71. PMID 18004879 DOI: 10.1021/bi7013773  1
2007 Prokaeva T, Spencer B, Kaut M, Ozonoff A, Doros G, Connors LH, Skinner M, Seldin DC. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis and Rheumatism. 56: 3858-68. PMID 17968927 DOI: 10.1002/art.22959  1
2007 Sanchorawala V, Seldin DC. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 261-9. PMID 17968685 DOI: 10.1080/13506120701613984  1
2007 Sanchorawala V, Skinner M, Quillen K, Finn KT, Doros G, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. Blood. 110: 3561-3. PMID 17673601 DOI: 10.1182/blood-2007-07-099481  1
2007 Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk JL, Doros G, Fisher C, Skinner M, Seldin DC. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis Bone Marrow Transplantation. 40: 557-562. PMID 17589534 DOI: 10.1038/sj.bmt.1705746  1
2007 Kos CA, Ward JE, Malek K, Sanchorawala V, Wright DG, O'Hara C, Connors L, Skinner M, Seldin DC. Association of acquired von Willebrand syndrome with AL amyloidosis. American Journal of Hematology. 82: 363-7. PMID 17205535 DOI: 10.1002/ajh.20829  1
2007 Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC. Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood. 109: 492-6. PMID 16960148 DOI: 10.1182/blood-2006-07-030544  1
2006 Seldin DC, Sanchorawala V. Adapting to AL amyloidosis. Haematologica. 91: 1591-5. PMID 17145594  1
2006 Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biological Chemistry. 387: 1175-87. PMID 16972784 DOI: 10.1515/BC.2006.145  1
2006 Seldin DC, Anderson JJ, Skinner M, Malek K, Wright DG, Quillen K, Finn K, Oran B, Sanchorawala V. Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65. Blood. 108: 3945-7. PMID 16926284 DOI: 10.1182/blood-2006-06-029728  1
2006 Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplantation. 38: 339-43. PMID 16862166 DOI: 10.1038/sj.bmt.1705447  1
2006 Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. The Journal of Clinical Investigation. 116: 1913-23. PMID 16823489 DOI: 10.1172/JCI27933  1
2006 Sanchorawala V, Blanchard E, Seldin DC, O'Hara C, Skinner M, Wright DG. AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes American Journal of Hematology. 81: 692-695. PMID 16795060 DOI: 10.1002/ajh.20635  1
2005 Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 12: 210-5. PMID 16399645 DOI: 10.1080/13506120500352339  1
2005 Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Research. 65: 11375-83. PMID 16357145 DOI: 10.1158/0008-5472.CAN-05-1602  1
2005 Dominguez I, Mizuno J, Wu H, Imbrie GA, Symes K, Seldin DC. A role for CK2alpha/beta in Xenopus early embryonic development. Molecular and Cellular Biochemistry. 274: 125-31. PMID 16342412 DOI: 10.1007/s11010-005-3073-5  1
2005 Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Molecular and Cellular Biochemistry. 274: 63-7. PMID 16342409 DOI: 10.1007/s11010-005-3078-0  1
2005 Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, Sherr DH, Seldin DC. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicologic Pathology. 33: 726-37. PMID 16263698 DOI: 10.1080/01926230500352226  1
2005 Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Molecular and Cellular Biology. 25: 10136-47. PMID 16260626 DOI: 10.1128/MCB.25.22.10136-10147.2005  1
2005 Sanchorawala V, Seldin DC, Magnani B, Skinner M, Wright DG. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis Bone Marrow Transplantation. 36: 597-600. PMID 16044137 DOI: 10.1038/sj.bmt.1705106  1
2005 Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Research. 65: 5792-801. PMID 15994955 DOI: 10.1158/0008-5472.CAN-05-1021  1
2005 Oran B, Malek K, Sanchorawala V, Wright DG, Quillen K, Finn KT, La Valley M, Skinner M, Seldin DC. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis Bone Marrow Transplantation. 35: 567-575. PMID 15665842 DOI: 10.1038/sj.bmt.1704826  1
2004 Sipe JD, Seldin DC. Xth International Symposium on Amyloid and Amyloidosis April 18-22, 2004 (selected highlights) Tours, Loire Valley, France. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 11: 268-72. PMID 15678763 DOI: 10.1080/13506120400016257  1
2004 Dominguez I, Mizuno J, Wu H, Song DH, Symes K, Seldin DC. Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. Developmental Biology. 274: 110-24. PMID 15355792 DOI: 10.1016/j.ydbio.2004.06.021  1
2004 Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 104: 1888-93. PMID 15155460 DOI: 10.1182/blood-2004-01-0089  1
2004 Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Annals of Internal Medicine. 140: 85-93. PMID 14734330  1
2004 Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: Results of a prospective randomized trial Bone Marrow Transplantation. 33: 381-388. PMID 14676787 DOI: 10.1038/sj.bmt.1704346  1
2003 Seldin DC. Diagnosis and treatment of Al amyloidosis. Clinical Advances in Hematology & Oncology : H&O. 1: 154-5. PMID 16224395  1
2003 Oran B, Wright DG, Seldin DC, McAneny D, Skinner M, Sanchorawala V. Spontaneous rupture of the spleen in AL amyloidosis American Journal of Hematology. 74: 131-135. PMID 14508801 DOI: 10.1002/ajh.10389  1
2003 Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 124: 969-77. PMID 12970025 DOI: 10.1378/chest.124.3.969  1
2003 Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Molecular and Cellular Biology. 23: 5738-54. PMID 12897145 DOI: 10.1128/MCB.23.16.5738-5754.2003  1
2003 Song DH, Dominguez I, Mizuno J, Kaut M, Mohr SC, Seldin DC. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. The Journal of Biological Chemistry. 278: 24018-25. PMID 12700239 DOI: 10.1074/jbc.M212260200  1
2003 Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney International. 63: 1868-73. PMID 12675865 DOI: 10.1046/j.1523-1755.2003.00936.x  1
2003 Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clinical Lymphoma. 3: 241-6. PMID 12672274  1
2003 Ramirez MI, Millien G, Hinds A, Cao Y, Seldin DC, Williams MC. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Developmental Biology. 256: 61-72. PMID 12654292 DOI: 10.1016/S0012-1606(02)00098-2  1
2003 Casserly LF, Fadia A, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney International. 63: 1051-7. PMID 12631087 DOI: 10.1046/j.1523-1755.2003.00813.x  1
2002 Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Research. 62: 6770-8. PMID 12438279  1
2002 Seldin DC. AL amyloidosis, a curable disease? Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 9: 203-6. PMID 12408686  1
2002 Miller SJ, Lou DY, Seldin DC, Lane WS, Neel BG. Direct identification of PTEN phosphorylation sites Febs Letters. 528: 145-153. PMID 12297295 DOI: 10.1016/S0014-5793(02)03274-X  1
2002 Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE, Cardiff RD. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. The American Journal of Pathology. 161: 1087-97. PMID 12213737 DOI: 10.1016/S0002-9440(10)64269-1  1
2002 Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene. 21: 5548-56. PMID 12165853 DOI: 10.1038/sj.onc.1205686  1
2002 Channavajhala P, Seldin DC. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene. 21: 5280-8. PMID 12149649 DOI: 10.1038/sj.onc.1205640  1
2002 Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. British Journal of Haematology. 117: 886-9. PMID 12060126 DOI: 10.1046/j.1365-2141.2002.03541.x  1
2001 Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC. Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Molecular and Cellular Biochemistry. 227: 153-65. PMID 11827167 DOI: 10.1023/A:1013108822847  1
2001 Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis Bone Marrow Transplantation. 28: 637-642. PMID 11704785 DOI: 10.1038/sj.bmt.1703200  1
2001 Shen J, Channavajhala P, Seldin DC, Sonenshein GE. Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha. Journal of Immunology (Baltimore, Md. : 1950). 167: 4919-25. PMID 11673497  1
2001 Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene. 20: 3247-57. PMID 11423974 DOI: 10.1038/sj.onc.1204411  1
2001 Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease Annals of Internal Medicine. 134: 746-753. PMID 11329232  1
2001 Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Research. 61: 3810-8. PMID 11325857  1
2001 Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: Incidence, bleeding manifestations, and response to high-dose chemotherapy Blood. 97: 1885-1887. PMID 11238135 DOI: 10.1182/blood.V97.6.1885  1
2000 Song DH, Sussman DJ, Seldin DC. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. The Journal of Biological Chemistry. 275: 23790-7. PMID 10806215 DOI: 10.1074/jbc.M909107199  1
2000 Ford HL, Landesman-Bollag E, Dacwag CS, Stukenberg PT, Pardee AB, Seldin DC. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. The Journal of Biological Chemistry. 275: 22245-54. PMID 10801845 DOI: 10.1074/jbc.M002446200  1
1999 Xu X, Toselli PA, Russell LD, Seldin DC. Globozoospermia in mice lacking the casein kinase ii α catalytic subunit Nature Genetics. 23: 118-121. PMID 10471512 DOI: 10.1038/12729  1
1999 Xu X, Landesman-Bollag E, Channavajhala PL, Seldin DC. Murine protein kinase CK2: gene and oncogene. Molecular and Cellular Biochemistry. 191: 65-74. PMID 10094394  1
1998 Rifkin IR, Channavajhala PL, Kiefer HL, Carmack AJ, Landesman-Bollag E, Beaudette BC, Jersky B, Salant DJ, Ju ST, Marshak-Rothstein A, Seldin DC. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. Journal of Immunology (Baltimore, Md. : 1950). 161: 5164-70. PMID 9820486  1
1998 Wang F, Seldin DC, Annis B, Trocha A, Johnson RP. Immune modulation of human B lymphocytes by gene transfer with recombinant Epstein-Barr virus amplicons Journal of Virological Methods. 72: 81-93. PMID 9672135 DOI: 10.1016/S0166-0934(98)00023-8  1
1998 Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene. 16: 2965-74. PMID 9662328 DOI: 10.1038/sj.onc.1201854  1
1998 Xu X, Rich ES, Seldin DC. Murine protein kinase CK2 alpha': cDNA and genomic cloning and chromosomal mapping. Genomics. 48: 79-86. PMID 9503019 DOI: 10.1006/geno.1997.5154  1
1996 Wasik MA, Seldin DC, Butmarc JR, Gertz R, Marti R, Maslinski W, Kadin ME. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder Leukemia and Lymphoma. 23: 125-136. PMID 9021695  1
1996 Kelliher MA, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. The Embo Journal. 15: 5160-6. PMID 8895560  1
1995 Seldin DC. New models of lymphoma in transgenic mice Current Opinion in Immunology. 7: 665-673. PMID 8573310 DOI: 10.1016/0952-7915(95)80075-1  1
1995 Seldin DC, Leder P. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science (New York, N.Y.). 267: 894-7. PMID 7846532  1
1994 Seldin DC, Leder P. Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proceedings of the National Academy of Sciences of the United States of America. 91: 2140-4. PMID 8134361  1
1993 Skoda RC, Seldin DC, Chiang MK, Peichel CL, Vogt TF, Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. The Embo Journal. 12: 2645-53. PMID 8334987  1
1986 Stevens RL, Lee TDG, Seldin DC, Austen KF, Befus AD, Bienenstock J. Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans Journal of Immunology. 137: 291-295. PMID 3086452  1
1986 Seldin DC, Caulfield JP, Hein A, Osathanondh R, Nabel G, Schlossman SF, Stevens RL, Austen KF. Biochemical and phenotypic characterization of human basophilic cells derived from dispersed fetal liver with murine T cell factors. Journal of Immunology (Baltimore, Md. : 1950). 136: 2222-30. PMID 2419426  1
1985 Seldin DC, Adelman S, Austen KF, Stevens RL, Hein A, Caulfield JP, Woodbury RG. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proceedings of the National Academy of Sciences of the United States of America. 82: 3871-5. PMID 3923482 DOI: 10.1073/pnas.82.11.3871  1
1985 Robin JL, Seldin DC, Austen KF, Lewis RA. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids Journal of Immunology. 135: 2719-2726. PMID 3161947  1
1985 Seldin DC, Austen KF, Stevens RL. Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate Di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells Journal of Biological Chemistry. 260: 11131-11139. PMID 2411730  1
1984 Seldin DC, Seno N, Austen KF, Stevens RL. Analysis of polysulfated chondroitin disaccharides by high-performance liquid chromatography Analytical Biochemistry. 141: 291-300. PMID 6437272 DOI: 10.1016/0003-2697(84)90459-7  1
1984 Stevens RL, Bloes WF, Seldin DC, Razin E, Katz HR, Austen KF. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype Journal of Immunology. 133: 2674-2680. PMID 6332858  1
1984 Seldin DC, Stevens RL, Austen KF. Homologous proteoglycans (PG) of histamine-secreting cells can be distinguished biochemically Federation Proceedings. 43.  1
1983 Pinkus GS, Maier M, Seldin DC, ole-MoiYoi OK, Austen KF, Spragg J. Immunohistochemical localization of glandular kallikrein in the endocrine and exocrine human pancreas Journal of Histochemistry and Cytochemistry. 31: 1279-1288. PMID 6194204  1
1979 Ole-Moiyoi O, Seldin DC, Spragg J. Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase Proceedings of the National Academy of Sciences of the United States of America. 76: 3612-3616. PMID 386342  1
Show low-probability matches.